AnodyneWiki

Methylone

MDMC
Methylone
Salts
[]
Methylone hydrochloride
Methylone hydrochloride
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass207.23 g/mol [1]
Predicted LogP0.6 [1]
Structural Identifiers
[]
Molecular formulaC11H13NO3
IUPAC name1-(1,3-benzodioxol-5-yl)-2-(methylamino)propan-1-one
SMILESCC(C(=O)C1=CC2=C(C=C1)OCO2)NC
InChIInChI=1S/C11H13NO3/c1-7(12-2)11(13)8-3-4-9-10(5-8)15-6-14-9/h3-5,7,12H,6H2,1-2H3
InChIKeyVKEQBMCRQDSRET-UHFFFAOYSA-N
CAS number186028-79-5
UNIIL4I4B1R01F
PubChem CID45789647
Pharmacokinetics[]
Onset0.5 hours
Elimination half-life5.8–6.9 hours[3]
Duration of action2–3.5 hours
MetabolismCYP2D6, CYP1A2, CYP2B6, and CYP2C19, COMT. [https://www.researchgate.net/figure/Common-routes-of-metabolism-for-methylone-3-Hydroxy-4-methoxy-N-methylcathinone-and_fig3_326760071]
Routes of administrationCommon: oral, insufflation, Uncommon: <abbr title="Intravenous">IV</abbr> or <abbr title="Intramuscular">IM</abbr> injection, rectal

Methylone (also known as 2-Methylamino-1-(3,4-methylenedioxyphenyl)propan-1-one, Bk-mdma, 3,4-Methylenedioxy-N-methylcathinone, Methylenedioxymethcathinone, J899.632f, β-keto-3,4-methylenedioxymethamphetamine, 3,4-methylenedioxy-N-methylcathinonmethylone, 1-Propanone, 1-(1,3-benzodioxol-5-yl)-2-(methylamino)-, βK-MDMA or M1 (psychedelic)) is a substance of the 3,4-methylenedioxyphenethylamine and cathinone class.

Chemistry

Salts []

Methylone is typically found in the form of its hydrochloride salt.

 []

Methylone is a racemic mixture of the (optical activity ( + / - )).

Stereoisomers from PubChem

Methylone matches Lipinski's rule of five.

There are currently 14 reagent-interactions on

ReagentColor changeDescription
Marquisbright yellow
MeckeYellow -> Orange
Mandelinyellow/green > brown
Liebermannyellow > black
Froehdebright yellow
Robadopegrey / brown
Simon'sfaint blue
Ehrlichno color change
Hofmannno color change
Scottno color change
Morrispale green
Zimmermanndark violet after 5 minutes
Gallicyellow
Folinno color change

Pharmacology

Mechanism of action []

A reproducible, simple, and small-scale method for determining the re-uptake and release of monoamines (dopamine, serotonin (5-HT) and norepinephrine) using rat brain synaptosomes /was developed/. These assays were then applied to study the effects of different kinds of non-medically used psychoactive drugs on monoamine re-uptake and release. The phenethylamine derivatives, 4-fluoroamphetamine, 2-methylamino-3,4-methylene-dioxy-propiophenone (methylone), 1-(1,3-benzodioxol-5-yl)-2-butanamine (BDB), and N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (MBDB), had strong inhibitory effects on the re-uptake of dopamine, 5-HT and norepinephrine. 4-Fluoroamphetamine, methylone and BDB also strongly increased the release of the three monoamines, but MBDB increased 5-HT and norepinephrine release, but had little effect on dopamine release. However, 2,5-dimethoxy-4-iodophenethylamine (2C-I), 2,5-dimethoxy-4-ethylphenethylamine (2C-E), 2,5-dimethoxy-4-chlorophenethylamine (2C-C), 2,4,5-trimethoxyamphetamine (TMA-2) and 2,4,6-trimethoxyamphetamine (TMA-6), which are methoxylated phenethylamine derivatives, slightly influenced the re-uptake and release of monoamines. Alpha-metyltryptamine (AMT), a tryptamine derivative, was one of the strongest re-uptake inhibitors and releasers of the three monoamines. The tryptamine derivative, 5-methoxy-alpha-methyltryptamine (5-MeO-AMT), also strongly inhibited re-uptake and increased the release of the three monoamines. N,N-dipropyltryptamine (DPT), 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), 5-methoxy-N,N-methylisopropyltryptamine (5-MeO-MIPT), and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) inhibited monoamine re-uptake, but had a few effects on monoamine release. 1-(3-Chlorophenyl)piperazine (3CPP) and 1-(methoxyphenyl)piperazine (4MPP), which are piperazine derivatives, inhibited monoamine re-uptake and accelerated their release. The results suggest that some designer drugs strongly act on the central nerve system to the same extent as restricted drugs. [1]

Experience reports

Erowid

There are currently 30 experience reports involving methylone on : []

Reddit

There are currently 3 trip reports involving methylone on : []

 []

  • Australia: Methylone is a Schedule 9.
  • Brazil: Methylone is a F2.[4]
  • Canada: Methylone is a Schedule I.
  • United Kingdom: Methylone is a Class B under the "Misuse of Drugs Act 1971".
  • United States: Methylone is a Schedule I under the "Controlled Substances Act".
  • Germany: Methylone is a Anlage II under the "Betäubungsmittelgesetz (BtMG)".
  • United Nations: Methylone is a Schedule II [https://www.unodc.org/LSS/Substance/Details/40f647f3-b96c-4a7a-8139-88c0ff651983].
  • Other: Methylone is a <small></small>: I-P, SE: Förteckning I.[5][6]

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 45789647, Methylone. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/45789647
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Methylone. UNII: L4I4B1R01F. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/L4I4B1R01F
  3. Poyatos L, Lo Faro AF, Berardinelli D, Sprega G, Malaca S, Pichini S, Huestis MA, Papaseit E, Pérez-Mañá C, Busardò FP, Farré M. Methylone and MDMA Pharmacokinetics Following Controlled Administration in Humans. International Journal of Molecular Sciences. November 2022; 23(23). PMID 36498963. https://doi.org/10.3390/ijms232314636
  4. RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-07-24. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451
  5. Ustawa z dnia 15 kwietnia 2011 r. o zmianie ustawy o przeciwdziałaniu narkomanii ( Dz.U. 2011 nr 105 poz. 614 ). Internetowy System Aktów Prawnych. http://isap.sejm.gov.pl/DetailsServlet?id=WDU20111050614
  6. Läkemedelsverkets föreskrifter (LVFS 2011:10) om förteckningar över narkotika. Läkemedelsverket. https://www.lakemedelsverket.se/globalassets/dokument/lagar-och-regler/lvfs/lvfs-2011-10-konsoliderad.pdf

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 10:54:33
drugsprook2026-11-20 10:54:29
erowidok2026-11-20 10:54:35
gsrsok2026-11-20 10:54:30
hmdbmissing (hmdb.ca refused automated access to HMDB0254656)2026-11-20 10:54:29
keggmissing (no KEGG DRUG entry)2026-11-20 10:54:33
pubchemok2026-11-20 10:54:27
redditok2026-11-20 10:54:29
sidermissing (not in SIDER)2026-11-20 10:54:29
structureok2026-11-20 10:54:29
wikipediaok2026-11-20 10:54:29